Navigation Links
‘Obesity’ Acquires Permanent Resident Status in the US

Obesity has been a frequent flier in search of greener pastures, but now, gauging by the unconditional adulation it has received//, has decided on a permanent home in the United States of America. ‘O’ for omnipresent, obesity, is estimated to have entered into the lives of nearly one-third of U.S children, leaving them with a bagful of unwholesome fat and a life time of woes to follow.

Experts feel that anything above the 95th percentile in the height to weight ratio in children, is considered obese. William Cochran, head of the Pediatric Weight Management Program at Geisinger Clinic in Danville, Pa, said “If your child's weight is jumping up percentiles on the weight charts at annual checkups, it could be a red flag that something must be done.”

Experts feel that it is important to seek medical intervention to gauge the eating and physical activity habits, before the child reaches the danger mark. Russell Pate, professor of exercise science at the University of South Carolina, and colleagues put a few kids on a basic treadmill test, and much to their dismay, found that kids simply tired out and couldn’t complete a simple cardiovascular test. This test led to the inference that nearly a third of kids are obese.

Pate said "About half the overweight adolescents failed to meet the fitness standard, but a large majority of the normal weight kids met it." The warning bell has struck; It is no exaggeration that unfit kids grow up to be unfit adults. Tomorrow may be too late, its time to act now.


Page: 1

Related medicine news :

1. Ossur Acquires the U.S. Orthopaedics Company
2. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
3. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
4. Premier Army Hospital Acquires PET-CT Scanner
5. Indoco Remedies Acquires La Nova Chem
6. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
7. AIIMS Acquires Four-Armed Robot to Assist in Surgeries
8. Apollos Global Arm Acquires US-based Firm
9. Indias Wockhardt Acquires Irish Firm
10. Battle against Gum Disease Acquires new Weapon
11. Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: